NCT05610293

Brief Summary

The purpose of this study is to investigate the risk of recurrence and metastasis in patients treated with different surgical margins (5mm vs 10mm) for a T1 squamous cell carcinoma of the lip.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2021

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 2, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 9, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

August 16, 2023

Status Verified

August 1, 2023

Enrollment Period

2.2 years

First QC Date

November 2, 2022

Last Update Submit

August 15, 2023

Conditions

Keywords

Disease free survivalMulticenterHistological margin

Outcome Measures

Primary Outcomes (1)

  • Tumor-free survival surgical margins

    Difference in tumor-free survival of patients treated with a 5mm surgical margin versus 10mm surgical margin for a T1 SCC on the lip. An event was refered to as the occurrence of recurrence or metastasis.

    5 years after surgical treatment

Secondary Outcomes (1)

  • Tumor-free survival histologic margins

    5 years after surgical treatment

Study Arms (2)

5mm surgical margin

Patients treated with a 5mm surgical margin for a T1 SCC of the lip.

10mm surgical margin

Patients treated with a 10mm surgical margin for a T1 SCC of the lip.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Data from patients are collected retrospectively using data from the Pathological Anatomical National Automated Archive (PALGA). These are data from patients treated at one of the following four centers in the Netherlands: MUMC+, Radboudumc, Zuyderland MC, CZE.

You may qualify if:

  • patients of 18 years and older
  • with a T1 cutaneous squamous cell carcinoma of the lip (including the cutaneous lip, vermillion border, vermillion and mucosal involvement).
  • who received surgical treatment
  • treated at one of the following centers: Maastricht University Medical Center+ (MUMC+), Radboud University Medical Center (Radboudumc), Zuyderland Medical Center (Zuyderland MC), Catharina Hospital Eindhoven (CZE).

You may not qualify if:

  • malignancies other than cutaneous squamous cell carcinoma
  • Oropharyngeal cancer
  • patients with stage T2-T4 cutaneous squamous cell caricnomas of the lip

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Radboud UMC

Nijmegen, Gelderland, Netherlands

Location

Catharina Hospital

Eindhoven, Netherlands

Location

Zuyderland Medical Center

Heerlen, Netherlands

Location

Related Publications (7)

  • Kerawala C, Roques T, Jeannon JP, Bisase B. Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016 May;130(S2):S83-S89. doi: 10.1017/S0022215116000499.

    PMID: 27841120BACKGROUND
  • de Visscher JG, Grond AJ, Botke G, van der Waal I. Results of radiotherapy for squamous cell carcinoma of the vermilion border of the lower lip. A retrospective analysis of 108 patients. Radiother Oncol. 1996 Apr;39(1):9-14. doi: 10.1016/0167-8140(96)01716-1.

    PMID: 8735488BACKGROUND
  • Kelleners-Smeets NW, Bekkenk MW, de Haas ER. [Skin cancer: from smearing to cutting]. Ned Tijdschr Geneeskd. 2013;157(12):A5602. Dutch.

    PMID: 23515035BACKGROUND
  • Biasoli ER, Valente VB, Mantovan B, Collado FU, Neto SC, Sundefeld ML, Miyahara GI, Bernabe DG. Lip Cancer: A Clinicopathological Study and Treatment Outcomes in a 25-Year Experience. J Oral Maxillofac Surg. 2016 Jul;74(7):1360-7. doi: 10.1016/j.joms.2016.01.041. Epub 2016 Jan 30.

    PMID: 26917204BACKGROUND
  • de Visscher JG, Gooris PJ, Vermey A, Roodenburg JL. Surgical margins for resection of squamous cell carcinoma of the lower lip. Int J Oral Maxillofac Surg. 2002 Apr;31(2):154-7. doi: 10.1054/ijom.2002.0232.

    PMID: 12102412BACKGROUND
  • Joo YH, Cho JK, Koo BS, Kwon M, Kwon SK, Kwon SY, Kim MS, Kim JK, Kim H, Nam I, Roh JL, Park YM, Park IS, Park JJ, Shin SC, Ahn SH, Won S, Ryu CH, Yoon TM, Lee G, Lee DY, Lee MC, Lee JK, Lee JC, Lim JY, Chang JW, Jang JY, Chung MK, Jung YS, Cho JG, Choi YS, Choi JS, Lee GH, Chung PS. Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol. 2019 May;12(2):107-144. doi: 10.21053/ceo.2018.01816. Epub 2019 Feb 2.

    PMID: 30703871BACKGROUND
  • O'Sullivan B. UICC manual of clinical oncology: John Wiley & Sons; 2015.

    BACKGROUND

Related Links

MeSH Terms

Conditions

Lymphoid Interstitial PneumoniaLip NeoplasmsCarcinoma, Squamous CellMargins of ExcisionRecurrenceNeoplasm Metastasis

Condition Hierarchy (Ancestors)

Mouth NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsLip DiseasesMouth DiseasesStomatognathic DiseasesCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasms, Squamous CellMorphological and Microscopic FindingsPathological Conditions, Signs and SymptomsDisease AttributesPathologic ProcessesNeoplastic Processes

Study Officials

  • K Mosterd, MD, PhD

    Maastricht University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2022

First Posted

November 9, 2022

Study Start

April 1, 2021

Primary Completion

July 1, 2023

Study Completion

November 1, 2023

Last Updated

August 16, 2023

Record last verified: 2023-08

Locations